GENENTECH INC.

In News

Bridging Medical Needs and Analytical Development - Chromatography Online

Chromatography Online - May 26, 2026

Ventus Therapeutics Enters into a Collaboration and License Agreement with Genentech to Discover and Develop Small-Molecule Medicines Using Ventus’ ReSOLVE® Platform - Ventus Therapeutics

Ventus Therapeutics - Oct 21, 2025

Genentech, TD Bank innovation leaders reveal why they back AI defensive patent organisation - IAM Media

IAM Media - May 08, 2026

Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing - Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center - Apr 19, 2026

Genentech licenses Sanegene’s RNAi asset in $1.7B deal - BioWorld News

BioWorld News - Feb 03, 2026

Biogen owes Genentech $88 million in MS drug dispute, US judge says - Reuters

Reuters - Oct 01, 2025

Drugmaker Genentech supersizing investment, hiring plans in the Triangle - WRAL

WRAL - Jan 20, 2026

Biotech company Genentech is doubling its investment into Holly Springs - Axios

Axios - Jan 20, 2026

With one drug in the clinic and another coming soon, this startup just raised $38 million - The Business Journals

The Business Journals - May 06, 2026

Andrew Chan Talks Transformative Medicines Nov. 17 - Research Horizons

Research Horizons - Oct 31, 2025

Biogen Told To Pay Genentech $88M After IP Royalties Mistrial - Law360

Law360 - Sep 30, 2025

Genentech’s Latest Layoffs Bring Total to Nearly 350 This Year - BioSpace

BioSpace - Oct 29, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment